Cipla Eyes Entry into India’s Weight Management Market

⚕️

Ltd is set to foray into the growing Indian weight management segment, tapping into rising obesity-related healthcare demand. Alongside this move, the pharma major is bolstering its CNS portfolio after in-licensing Sanofi’s India CNS product range. Cipla is also exploring further acquisitions in niche areas like ADHD and Parkinson’s. Additionally, it is developing four novel drugs targeting antimicrobial resistance.